NYSE: LYB
LyondellBasell
Materials · Industrial Organic Chemicals
52-week range
$41.58$83.94
Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.Figures shown are for the trailing 12 months to Sep 30, 2026. Hover or tap a column for another year.$18.6B
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 31, 2016 | $34.5B |
| FY2017, ended Dec 31, 2017 | $43.5B |
| FY2018, ended Dec 31, 2018 | $30.9B |
| FY2019, ended Dec 31, 2019 | $31.5B |
| FY2020, ended Dec 31, 2020 | $30.6B |
| FY2021, ended Dec 31, 2021 | $30.3B |
| FY2022, ended Dec 31, 2022 | $27.1B |
| FY2023, ended Dec 31, 2023 | $30.9B |
| FY2024, ended Dec 31, 2024 | $24.0B |
| FY2025, ended Dec 31, 2025 | $13.9B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $18.6B |
Revenue
By fiscal year, then the trailing 12 months.Figures shown are for the trailing 12 months to Sep 30, 2026. Hover or tap a column for another year.$32.0B
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $29.2B |
| FY2017, ended Dec 31, 2017 | $34.5B |
| FY2018, ended Dec 31, 2018 | $39.0B |
| FY2019, ended Dec 31, 2019 | $34.7B |
| FY2020, ended Dec 31, 2020 | $27.8B |
| FY2021, ended Dec 31, 2021 | $46.2B |
| FY2022, ended Dec 31, 2022 | $50.5B |
| FY2023, ended Dec 31, 2023 | $33.3B |
| FY2024, ended Dec 31, 2024 | $33.4B |
| FY2025, ended Dec 31, 2025 | $30.2B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $32.0B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.Figures shown are for the trailing 12 months to Sep 30, 2026. Hover or tap a column for another year.Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $3.84B | $3.36B |
| FY2017, ended Dec 31, 2017 | $4.88B | $3.66B |
| FY2018, ended Dec 31, 2018 | $4.69B | $3.37B |
| FY2019, ended Dec 31, 2019 | $3.40B | $2.27B |
| FY2020, ended Dec 31, 2020 | $1.43B | $1.46B |
| FY2021, ended Dec 31, 2021 | $5.62B | $5.74B |
| FY2022, ended Dec 31, 2022 | $3.89B | $4.23B |
| FY2023, ended Dec 31, 2023 | $2.12B | $3.41B |
| FY2024, ended Dec 31, 2024 | $1.37B | $1.98B |
| FY2025, ended Dec 31, 2025 | −$738M | $384M |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $1.30B | $2.41B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.Figures shown are for the trailing 12 months to Sep 30, 2026. Hover or tap a column for another year.$3.23B
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $875M |
| FY2017, ended Dec 31, 2017 | $1.52B |
| FY2018, ended Dec 31, 2018 | $332M |
| FY2019, ended Dec 31, 2019 | $858M |
| FY2020, ended Dec 31, 2020 | $1.76B |
| FY2021, ended Dec 31, 2021 | $1.47B |
| FY2022, ended Dec 31, 2022 | $2.15B |
| FY2023, ended Dec 31, 2023 | $3.39B |
| FY2024, ended Dec 31, 2024 | $3.38B |
| FY2025, ended Dec 31, 2025 | $3.44B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $3.23B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.Figures shown are for the trailing 12 months to Sep 30, 2026. Hover or tap a column for another year.$12.3B
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Dec 31, 2016 | $8.98B |
| FY2017, ended Dec 31, 2017 | $8.62B |
| FY2018, ended Dec 31, 2018 | $9.39B |
| FY2019, ended Dec 31, 2019 | $12.1B |
| FY2020, ended Dec 31, 2020 | $16.0B |
| FY2021, ended Dec 31, 2021 | $11.6B |
| FY2022, ended Dec 31, 2022 | $11.3B |
| FY2023, ended Dec 31, 2023 | $11.2B |
| FY2024, ended Dec 31, 2024 | $11.1B |
| FY2025, ended Dec 31, 2025 | $12.9B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $12.3B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Down 19.7% since 2016.Figures shown are for the trailing 12 months to Sep 30, 2026. Hover or tap a column for another year.323M
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | 403M |
| FY2017, ended Dec 31, 2017 | 395M |
| FY2018, ended Dec 31, 2018 | 371M |
| FY2019, ended Dec 31, 2019 | 334M |
| FY2020, ended Dec 31, 2020 | 334M |
| FY2021, ended Dec 31, 2021 | 328M |
| FY2022, ended Dec 31, 2022 | 326M |
| FY2023, ended Dec 31, 2023 | 325M |
| FY2024, ended Dec 31, 2024 | 323M |
| FY2025, ended Dec 31, 2025 | 322M |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | 323M |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.Figures shown are for the trailing 12 months to Sep 30, 2026. Hover or tap a column for another year.Net: $101M more issued than bought back
Show tableHide table
| Period | Bought back | Paid to employees |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $2.94B | $38.0M |
| FY2017, ended Dec 31, 2017 | $866M | $55.0M |
| FY2018, ended Dec 31, 2018 | $1.85B | $39.0M |
| FY2019, ended Dec 31, 2019 | $3.75B | $48.0M |
| FY2020, ended Dec 31, 2020 | $4.00M | $55.0M |
| FY2021, ended Dec 31, 2021 | $463M | $66.0M |
| FY2022, ended Dec 31, 2022 | $420M | $70.0M |
| FY2023, ended Dec 31, 2023 | $211M | $91.0M |
| FY2024, ended Dec 31, 2024 | $195M | $91.0M |
| FY2025, ended Dec 31, 2025 | $201M | $91.0M |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $0 | $101M |
Revenue (TTM)
$32.0B
+3.5% YoY
Net income (TTM)
$1.30B
n/m YoY
Cash
$3.23B
+80.9% YoY
Total debt
$12.3B
+4.0% YoY
Valuation
At current price- Market Cap
- $22.2B
- P/E
- 17.0×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 0.7×
- Price / Book
- 2.0×
- EV / EBITDA
- 7.4×
Growth
Trailing 12 months- Revenue (TTM)
- $32.0B
- Revenue Growth YoY
- 3.5%
- Revenue CAGR 3Y
- −15.8%
- Revenue CAGR 5Y
- 1.7%
- EPS Growth YoY
- n/m. Diluted EPS, TTM vs. TTM a year earlier
- Net Income Growth YoY
- n/m. TTM vs. TTM a year earlier
Profitability
Trailing 12 months- Gross Margin
- 14.3%
- Operating Margin
- 8.6%
- Net Margin
- 4.1%
- FCF Margin
- 7.6%
- Return on Equity
- 11.9%
Earnings
Trailing 12 months- Net Income
- $1.30B
- EPS (diluted)
- $3.97
- EBITDA
- $4.21B
- Operating Income
- $2.76B
Balance Sheet
As of Sep 30, 2026- Cash and cash equivalents
- $3.23B
- Total Debt
- $12.3B
- Net Debt
- $9.10B
- Total Assets
- $34.7B
- Total Liabilities
- $23.5B
- Shareholders' Equity
- $11.3B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $3.71B
- Capital Expenditure
- $1.29B
- Free Cash Flow
- $2.41B
Dividends and risk
Last 12 months- Dividend Yield
- 5.0%
- Dividend / Share
- $3.44
- Beta (5Y)
- 0.32
Every ratio is calculated from the company’s reported figures.
Note
Revenue is roughly flat year over year at $32.0B.
Strength
Operating margin widened 11.6 pts in a year, to 8.6%.
Note
Net debt of $9.10B is 2.2× EBITDA.
Note
Free cash flow of $2.41B, 7.6% of revenue.
Written by fixed rules from the reported figures, not by a person or an AI.
Latest report
Pro10-Q for the quarter ended Sep 30, 2026 · filed Oct 30, 2026
The score and findings for the newest report are part of CoreStock Pro, coming soon. Every earlier report is free.
Score of each annual report
0 to 100 · 60 means nothing notable · tap a column for its details
2025 · 10-K23Serious concerns
23Serious concerns
10-K for the fiscal year ended Dec 31, 2025
Filed Feb 20, 2026 · Read the filing on EDGAR
- Revenue fell 10% to $30.2 billion, and the company swung to a $738 million net loss from a $1.4 billion profit.
- Impairment charges of $1.25 billion, tied to the European petrochemical and global auto downturns, drove much of the loss.
- The quarterly dividend was cut about in half, from $1.37 to $0.69 per share, and credit terms were loosened to allow higher debt levels.
- The company agreed to sell four European sites, expecting a $700 million to $900 million loss at closing in the second quarter of 2026.
Business momentum
Sharp deterioration
“Operating income decreased by $2,338 million, or 122%, in 2025 compared to 2024.”
Outlook
Cautious
“We are aligning our first quarter of 2026 operating rates with global demand and plan to operate our O&P-Americas, O&P-EAI and I&D assets at approximately 85%, 75% and 85%, respectively.”
Financial stress
Moderate
“In 2025, we amended the Senior Revolving Credit Facility primarily to increase the maximum leverage ratio (as defined in the Credit Agreement) through 2027 unless we elect to terminate such provisions sooner.”
Tone against the previous report
More negative
Red flags
- Medium
Large write-down
“combined with the sustained decline in our market capitalization, drove non-cash impairment charges of $1,182 million within these segments”
- Medium
Other
“In February 2026, we declared a quarterly dividend of $0.69 per share, representing a $0.68 per share reduction from our fourth quarter 2025 dividend.”
- Medium
Other
“In connection with the sale, we expect to recognize a loss of approximately $700 million to $900 million upon closing, which includes a cash contribution of approximately $300 million to the sold businesses prior to closing.”
- Medium
Other
“Included in the amendment are certain limitations, including restrictions on dividend increases, if our leverage ratio is greater than or equal to 4.00 to 1.00, and share repurchases except to offset dilution.”
Positives
Cash savings plan beat its target, with more savings planned for 2026
“As of the end of 2025, the cash improvement plan achieved $800 million in annualized cash savings relative to our 2025 plan.”
Strong available liquidity from cash and unused credit lines
“We had total unused availability under our credit facilities of $4,650 million at December 31, 2025”
Early 2026 polyethylene market conditions look more supportive in the Americas
“In our O&P-Americas segment, tight year-end inventories, reduced supply and stronger seasonal demand are supportive for polyethylene price increase initiatives in the market.”
Concerns
Oversupply, trade disruption and lower oil prices squeezed margins across the industry
“Throughout 2025, petrochemical markets faced significant headwinds from global trade disruptions, falling oil prices and capacity additions which outpaced global demand growth.”
Core Americas segment profit more than halved
“EBITDA decreased by $1,301 million, or 53%, in 2025 compared to 2024.”
Operating cash flow fell and did not cover both capital spending and shareholder payouts
“During 2025, we generated $2.3 billion in cash from operating activities. We invested $1.9 billion in capital expenditures and returned $2.0 billion to shareholders through dividend payments and share repurchases.”
New risks since the previous report
European sale may be delayed or fail, possibly forcing the business to be wound down
“There can be no assurance that announced dispositions - including our European divestiture - will be successfully completed on the expected timeline or at all”
Inventory write-downs possible if market prices keep falling
“As of December 31, 2025, three of our nine LIFO inventory pools, with a combined carrying value of $1.6 billion, were valued close to their respective market values.”
Delayed growth projects could end up costing more
“In 2025, we announced the deferral of construction on our Flex-2 project in Channelview to preserve capital during the market downturn and also postponed the final investment decision on certain projects, such as MoReTec-2, which could result in increased costs.”
Credit agreement limits buybacks and dividend increases, constraining shareholder returns
“In September 2025, we amended our Senior Revolving Credit Facility which now restricts share repurchases, except to offset dilution.”
Biggest risks named
- Industry cycles and new capacity causing oversupply and lower margins
- Prolonged weakness in European petrochemicals and global auto demand
- Raw material, energy and oil price swings, plus trade disruptions
- Further impairments and execution risk on the European business sale
- Climate rules, carbon costs and restrictions on plastics
Artificial intelligence in this business: Mentioned
How the score adds up
| Starting point | 60 | |
| Business momentum | −15 | |
| Outlook | −2 | |
| Tone against the previous report | −2 | |
| Financial stress | −8 | |
| Red flags | −8.4 | |
| New risks | −2 | |
| Score | 23 | |
Written by AI (Claude Opus 5.5) from the report’s text. 17 of 17 quotes were found word for word in the filing; the rest are left out. Not investment advice.
All scored reports
| Period | Report | Filed | Score | Momentum | Red flags |
|---|---|---|---|---|---|
| 10-Q | Oct 30, 2026 | Pro | |||
| 10-K | Feb 20, 2026 | 23 | Sharp deterioration | 4 medium | |
| 10-K | Feb 27, 2025 | 38 | Sharp deterioration | 1 medium | |
| 10-K | Feb 22, 2024 | 39 | Sharp deterioration | 1 medium | |
| 10-K | Feb 23, 2023 | 50 | Mixed | 1 minor | |
| 10-K | Feb 24, 2022 | 72 | Strong improvement | 1 medium | |
| 10-K | Feb 25, 2021 | 37 | Sharp deterioration | 3 medium | |
| 10-K | Feb 20, 2020 | 49 | Weakening | None | |
| 10-K | Feb 21, 2019 | 57 | Mixed | None | |
| 10-K | Feb 22, 2018 | 76 | Strong improvement | None |
How these scores work
An AI model reads the management discussion, risk factors and legal sections of each report and records what they say, quoting the filing word for word. Fixed rules then turn those findings into a score from 0 to 100, where 60 means nothing notable either way. A score describes the report, not whether the stock is a good investment, and the AI may know how things turned out later, which can colour older scores. Read the methodology
From the 10-Q for Q3 FY2026 (period ended Sep 30, 2026), filed Oct 30, 2026. View filings on SEC EDGAR